Personal information

No personal information available

Activities

Collapse all

Works (6)

Addressing the Clinical Importance of Equilibrative Nucleoside Transporters in Drug Discovery and Development

Clinical Pharmacology & Therapeutics
2023-10 | Journal article
DOI: 10.1002/cpt.2984
Contributors: Raymond K. Hau; Stephen H. Wright; Nathan J. Cherrington
Source: check_circle
Crossref

In Vitro and In Vivo Models for Drug Transport Across the Blood-Testis Barrier

Drug Metabolism and Disposition
2023-09 | Journal article
DOI: 10.1124/dmd.123.001288
Contributors: Raymond K. Hau; Stephen H. Wright; Nathan J. Cherrington
Source: check_circle
Crossref

Mechanistic basis of increased susceptibility to nephrotoxicants in chronic liver disease

Current Opinion in Toxicology
2022-09 | Journal article
DOI: 10.1016/j.cotox.2022.100347
Contributors: Kayla L. Frost; Solène Marie; Nathan J. Cherrington
Source: check_circle
Crossref

Testicular disposition of clofarabine in rats is dependent on equilibrative nucleoside transporters

Pharmacology Research & Perspectives
2021-08 | Journal article
DOI: 10.1002/prp2.831
Contributors: Siennah R. Miller; Joseph L. Jilek; Meghan E. McGrath; Raymond K. Hau; Erin Q. Jennings; James J. Galligan; Stephen H. Wright; Nathan J. Cherrington
Source: check_circle
Crossref

Misregulation of membrane trafficking processes in human nonalcoholic steatohepatitis

Journal of Biochemical and Molecular Toxicology
2018-03 | Journal article
DOI: 10.1002/jbt.22035
Contributors: Anika L. Dzierlenga; Nathan J. Cherrington
Source: check_circle
Crossref

Impaired N‐linked glycosylation of uptake and efflux transporters in human non‐alcoholic fatty liver disease

Liver International
2017-07 | Journal article
DOI: 10.1111/liv.13362
Contributors: John D. Clarke; Petr Novak; April D. Lake; Rhiannon N. Hardwick; Nathan J. Cherrington
Source: check_circle
Crossref
How many people are using ORCID?